Predictive response variables to recombinant human erythropoietin treatment in patients with anemia and cancer

Medicina

Volumn 62, Issue 1, 2002, Pages 41-47

  Lastiri, Jose M ^a   Specterman, Sergio R ^a   Rendo, Pablo ^a   Pallotta, Maria G ^a   Varela, Mirta S ^a   Goldstein, Sofia ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Anemia and cancer; Erythropoietin; Quality of life; Response variables

Indexed keywords

CISPLATIN; CYTOKINE; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 6; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BREAST CANCER; CANCER; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFICACY; FEMALE; GERM CELL TUMOR; HEMATOLOGICAL PARAMETERS; HUMAN; LUNG CANCER; MALE; OVARY CANCER; PREDICTION; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; RETICULOCYTE COUNT; SARCOMA; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; BLOOD; CHI SQUARE DISTRIBUTION; DOSE RESPONSE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM; PHASE 2 CLINICAL TRIAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANEMIA; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0036372071     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The Approach to the Patient with Anemia
2. Principles of radiation therapy
3. Management of Anemia in Oncology
4. Anemia of Chronic Disease
5. Correction of the Anemia of End Stage Renal Disease with Recombinant Human Erythropoietin. Results of a Combined Phase I and II Clinical Trial
6. Multicenter Study of Recombinant Erythropoietin in Correction of Anemia in Rheumatoid Arthritis
7. Recombinant Erythropoietin for Patients with AIDS Treated with Zidovudine
8. Increased Preoperative Collectio of Autologous Blood with Recombinant Human Erythropoietin Therapy
9. A Randomized Placebo-Controlled Clinical Trial of Recombinant Human Erythropoietin in the Anemia of Prematurity
10. Erythropoiesis in multiple myeloma: Defective red cell production due to inappropriate erythropoietin production
11. Patients, caregiver, and Oncologist perceptions of cancer-related fatigue: Results of tripart assessment survey
12. The functional assessment of cancer therapy-anemia (FACT-an) Scale: A new tool for the assessment of outcomes in cancer anemia and fatigue
13. The impacy of Epoetin alfa on quality of life during cancer chemotherapy: A fresh look at an old problem
14. Anemia en los pacientes con neoplasias. Fisiología y Tratamiento
15. Anticancer drugs
16. The anemia of chronic disorders: Studies of marrow regulation and iron metabolism
17. Diagnosis of anemia. A skill building computer challenge orthopharmaceutical corporation
18. Transfusion-associated hepatitis and AIDS: What is the risk?
19. The effects of red blood cell transfusion on host inmune function
20. Recombinant human erythropoeitin in the anemia associated with multiple myeloma or non-Hodgkin"s lymphoma:Dose finding and identification of predictive response
21. Recombinant human erythropoietin (rHuEpo) for the treatment of the anemia of cancer
22. Erythropoietin for the treatment of anemia of malignancy associated with neoplasic bone marrow infiltration
23. Recombinant erythropoietin in patients with osteosarcoma and Ewing's sarcoma
24. Erythropoietin treatment of anemia associated with multiple myeloma
25. Recombinant erythropoietin (rHuEpo) is effective in correcting the anemia of multiple myeloma
26. Recombinant Human erythropoietin for the correction of anemia in different types of cancer
27. Recombinant erythropoietin therapy in cancer patients
28. Recombinant human erithropoietin and the anemia of cancer
29. Prospective evaluation of transfusion requirement of anemic cancer patient's chemotherapy
30. Prediction of response to erythropoietin treatment in chronic anemia of cancer
31. Quality-of-life benefit en chemotherapy patients treated with epetin alfa is independent of disease response or tumor type: Results from a prospective community Oncology Study
32. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community concology practice
33. Symposium: Quality of life and ethyropoeitin in anemia and cancer